Literature DB >> 588814

A chronic dose-ranging kinetic study of salicylate in man [proceedings].

L J Aarons, F Bochner, M Rowland.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 588814      PMCID: PMC1667884     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  3 in total

1.  Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man.

Authors:  G Levy; T Tsuchiya; L P Amsel
Journal:  Clin Pharmacol Ther       Date:  1972 Mar-Apr       Impact factor: 6.875

2.  Drug biotransformation interactions in man. I. Mutual inhibition in glucuronide formation of salicylic acid and salicylamide in man.

Authors:  G Levy; J A Procknal
Journal:  J Pharm Sci       Date:  1968-08       Impact factor: 3.534

3.  Application of salivary salicylate data to biopharmaceutical studies of salicylates.

Authors:  G Graham; M Rowland
Journal:  J Pharm Sci       Date:  1972-08       Impact factor: 3.534

  3 in total
  4 in total

1.  High unbound fraction of salicylate in plasma during intoxication.

Authors:  G Alván; U Bergman; L L Gustafsson
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

2.  Clinical pharmacokinetics of salicylates: a re-assessment.

Authors:  G Levy
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

3.  Pharmacokinetics of triflusal and its main metabolite HTB in healthy subjects following a single oral dose.

Authors:  J Ramis; R Mis; J Forn; J Torrent; E Gorina; F Jané
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Oct-Dec       Impact factor: 2.441

Review 4.  Drug structure-transport relationships.

Authors:  Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-11-24       Impact factor: 2.745

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.